An international initiative to identify genetic modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: the Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA)
-
* Corresponding author: Georgia Chenevix-Trench georgiaT@qimr.edu.au
Breast Cancer Research 2007, 9:104 doi:10.1186/bcr1670
Accesses
- Last 30 days: 43 accesses
- Last year: 498 accesses
- All time: 3188 accesses
Cited by
BioMed Central: 2 citations
|
Research article
Anna Mulligan, Fergus J Couch, Daniel Barrowdale, Susan M Domchek, Diana Eccles, Heli Nevanlinna, Susan J Ramus, Mark Robson, Mark Sherman, Amanda B Spurdle, Barbara Wappenschmidt, Andrew Lee, Lesley McGuffog, Sue Healey, Olga M Sinilnikova, Ramunas Janavicius, Thomas Hansen, Finn C Nielsen, Bent Ejlertsen, Ana Osorio et al. Breast Cancer Research 2011, 13:R110 (2 November 2011) |
|
Research article
D Gareth Evans, Andrew Shenton, Emma Woodward, Fiona Lalloo, Anthony Howell, Eamonn R Maher BMC Cancer 2008, 8:155 (30 May 2008) Counselling about the risks of breast and ovarian cancer for women who carry a BRCA1 or BRCA2 mutation should take into account the family history, because these women have a higher risk of cancer than the average population risk indicates.
|